Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,765.77 -11.01 -0.40%
FTSE 100 6,650.93 -45.86 -0.68%
DAX 8,283.27 -68.71 -0.82%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Fund Type: ETF
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: U.S.

Health Care Select Sector SPDR Fund

+ Add to Watchlist

XLV:US

49.2700 USD 0.0200 0.04%

As of 20:04:03 ET on 05/23/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Health Care Select Sector SPDR Fund (XLV)

Open: 48.8800 High - Low: 49.4300 - 48.7300 Primary Exchange: NYSE Arca
Volume: 6,668,420 52-Week Range: 35.3800 - 50.4000 Beta vs IXV: 0.9932

ETF Chart for XLV

No chart data available.
  • XLV:US 49.2700
  • 1D
  • 1M
  • 1Y
49.2700
Interactive XLV Chart

Previous Close

Fund Profile & Information for XLV

Health Care Select Sector SPDR Fund is an exchange-traded fund incorporated in the USA. The Fund's objective is to provide investment results that correspond to the performance of The Health Care Select Sector Index. The Index includes companies involved in health care equipment and supplies, health care providers and services, biotechnology & pharmaceuticals.

Inception Date: 1998-12-16 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XLV

NAV (on 2013-05-23) 49.2504
Assets (M) (on 2013-05-23) 7,378.4620
Shares out (M) 149.82
Market Cap (M) 7,381.40
% Premium 0.04
Average 52-Week % Premium -0.0019
Fund Leveraged N

Dividends for XLV

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2013-03-15) 0.1942
Dividend Yield (ttm) 1.64%

Performance for XLV

1-Month +2.24% 1-Year +39.01%
3-Month +14.04% 3-Year +21.98%
Year To Date +24.08% 5-Year +11.68%
Expense Ratio 0.18

Top Fund Holdings for XLV

Filing Date: 05/22/2013
Name Position Value % of Total
Johnson & Johnson 10,570,149 935,035,381 13.072%
Pfizer Inc 27,184,124 796,494,863 11.135%
Merck & Co Inc 11,428,534 533,826,823 7.463%
Gilead Sciences Inc 5,756,653 321,969,602 4.501%
Amgen Inc 2,830,071 295,827,322 4.136%
Bristol-Myers Squibb Co 6,222,883 288,741,771 4.037%
AbbVie Inc 5,976,967 279,482,977 3.907%
UnitedHealth Group Inc 3,907,261 243,344,215 3.402%
Biogen Idec Inc 913,634 212,940,676 2.977%
Eli Lilly & Co 3,774,824 207,313,334 2.898%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil